Ainsworth Game Technology Limited (ASX:AGI)

Theseus Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Revenue	264.06	284.86	248.29	220.16	159.52
Revenue Growth (YoY)	-7.30%	14.73%	12.78%	38.01%	6.78%
Cost of Revenue	103.81	109.62	88.82	82.14	69.96
Gross Profit	160.25	175.25	159.48	138.02	89.56
Selling, General & Admin	90.45	92.63	88.04	76.77	65.02
Research & Development	49.35	45.71	38.89	35.29	33.36
Other Operating Expenses	-4.88	0.47	10.85	15.78	-0.79
Operating Expenses	135.53	138.05	140.12	126.29	106.58
Operating Income	24.72	37.2	19.35	11.72	-17.02
Interest Expense	-2.12	-0.89	-1.15	-1.97	-2.4
Interest & Investment Income	4.05	7.19	7.74	2.82	1.06
Currency Exchange Gain (Loss)	9.64	-21.52	-4.2	8.23	-11.46
EBT Excluding Unusual Items	36.3	21.97	21.74	20.8	-29.82
Gain (Loss) on Sale of Investments	-	-13.18	-	-	-
Gain (Loss) on Sale of Assets	-0.26	-0.05	0.57	0.25	3.37
Asset Writedown	-2.07	-6.1	-7.76	-5.25	-32.72
Pretax Income	33.96	2.64	14.55	15.81	-59.17
Income Tax Expense	3.64	9.18	9.27	4.05	-5.76
Net Income	30.32	-6.54	5.28	11.75	-53.41
Net Income to Common	30.32	-6.54	5.28	11.75	-53.41
Net Income Growth	-	-	-55.04%	-	-
Shares Outstanding (Basic)	337	337	337	337	337
Shares Outstanding (Diluted)	345	337	353	345	337
Shares Change (YoY)	2.36%	-4.58%	2.45%	2.30%	-
EPS (Basic)	0.09	-0.02	0.02	0.03	-0.16
EPS (Diluted)	0.09	-0.02	0.02	0.03	-0.16
EPS Growth	-	-	-54.50%	-	-
Free Cash Flow	-5.65	16.72	-14.76	49.63	20.03
Free Cash Flow Per Share	-0.02	0.05	-0.04	0.14	0.06
Gross Margin	60.69%	61.52%	64.23%	62.69%	56.15%
Operating Margin	9.36%	13.06%	7.79%	5.33%	-10.67%
Profit Margin	11.48%	-2.30%	2.13%	5.34%	-33.48%
Free Cash Flow Margin	-2.14%	5.87%	-5.95%	22.54%	12.55%
EBITDA	50.13	59.74	39.96	26.67	5.34
EBITDA Margin	18.98%	20.97%	16.09%	12.12%	3.35%
D&A For EBITDA	25.41	22.54	20.61	14.95	22.35
EBIT	24.72	37.2	19.35	11.72	-17.02
EBIT Margin	9.36%	13.06%	7.79%	5.33%	-10.67%
Effective Tax Rate	10.72%	347.80%	63.69%	25.64%	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.